Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder

Authors: Mulders P.F.¹, Miller K.², Tchekmedyian N.S.³
Affiliations:
1. University Hospital Nijmegen
2. Universitatsklinikum Benjamin Franklin
3. Pacific Shores Medical Group
Issue: Vol 4, No 1 (2008)
Pages: 55
Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER
Published: 30.03.2008
URL: https://oncourology.abvpress.ru/oncur/article/view/1046
DOI: https://doi.org/10.17650/1726-9776-2008-4-1-55
ID: 1046

Cite item

Full Text

University Hospital Nijmegen

Author for correspondence.
Netherlands

Universitatsklinikum Benjamin Franklin

Berlin Germany

Pacific Shores Medical Group

Long Beach United States

Supplementary Files

Action

1. JATS XML